Northwestern Mutual Investment Management Company LLC Has $303,000 Position in Inogen Inc (NASDAQ:INGN)

Share on StockTwits

Northwestern Mutual Investment Management Company LLC lowered its stake in shares of Inogen Inc (NASDAQ:INGN) by 4.6% during the first quarter, HoldingsChannel reports. The institutional investor owned 3,182 shares of the medical technology company’s stock after selling 154 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in Inogen were worth $303,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of INGN. Janus Henderson Group PLC grew its position in Inogen by 15,943.5% during the first quarter. Janus Henderson Group PLC now owns 552,056 shares of the medical technology company’s stock worth $52,650,000 after buying an additional 548,615 shares in the last quarter. Norges Bank acquired a new stake in Inogen during the fourth quarter worth approximately $48,104,000. Thrivent Financial for Lutherans grew its position in Inogen by 210.5% during the fourth quarter. Thrivent Financial for Lutherans now owns 178,152 shares of the medical technology company’s stock worth $22,121,000 after buying an additional 120,785 shares in the last quarter. Jennison Associates LLC grew its position in Inogen by 90.2% during the fourth quarter. Jennison Associates LLC now owns 232,179 shares of the medical technology company’s stock worth $28,830,000 after buying an additional 110,098 shares in the last quarter. Finally, BlackRock Inc. grew its position in Inogen by 4.4% during the fourth quarter. BlackRock Inc. now owns 2,233,303 shares of the medical technology company’s stock worth $277,307,000 after buying an additional 93,873 shares in the last quarter. 98.63% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts recently issued reports on the company. Zacks Investment Research downgraded Inogen from a “buy” rating to a “hold” rating in a research report on Thursday, February 14th. BidaskClub cut Inogen from a “sell” rating to a “strong sell” rating in a research note on Friday, May 24th. Needham & Company LLC reiterated a “buy” rating and issued a $191.00 price target on shares of Inogen in a research note on Tuesday, April 9th. JPMorgan Chase & Co. cut Inogen from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $175.00 to $72.00 in a research note on Wednesday, May 8th. Finally, Stifel Nicolaus dropped their price target on Inogen from $160.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, May 8th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $121.60.

Shares of INGN traded up $1.06 during trading hours on Wednesday, reaching $67.15. The stock had a trading volume of 12,608 shares, compared to its average volume of 610,662. Inogen Inc has a 12 month low of $62.31 and a 12 month high of $287.79. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 28.87, a PEG ratio of 2.61 and a beta of 1.58. The company has a debt-to-equity ratio of 0.02, a quick ratio of 6.70 and a current ratio of 7.35.

Inogen (NASDAQ:INGN) last announced its quarterly earnings results on Tuesday, May 7th. The medical technology company reported $0.24 EPS for the quarter, missing the Zacks’ consensus estimate of $0.29 by ($0.05). Inogen had a net margin of 12.56% and a return on equity of 15.59%. The firm had revenue of $90.20 million during the quarter, compared to the consensus estimate of $89.69 million. During the same quarter in the previous year, the company posted $0.48 earnings per share. The firm’s revenue was up 14.1% on a year-over-year basis. As a group, equities analysts forecast that Inogen Inc will post 1.63 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This story was first published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/4369223/northwestern-mutual-investment-management-company-llc-has-303000-position-in-inogen-inc-nasdaqingn.html.

Inogen Company Profile

Inogen, Inc, a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Read More: What is the NASDAQ Stock Market?

Want to see what other hedge funds are holding INGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inogen Inc (NASDAQ:INGN).

Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sanofi  PT Set at €79.00 by Goldman Sachs Group
Sanofi PT Set at €79.00 by Goldman Sachs Group
AGNC Investment  Upgraded at BidaskClub
AGNC Investment Upgraded at BidaskClub
Cna Financial  Stock Price Up 0.4%
Cna Financial Stock Price Up 0.4%
H. Lundbeck A/S-  Reaches New 52-Week Low at $38.31
H. Lundbeck A/S- Reaches New 52-Week Low at $38.31
Critical Review: MSA Safety  vs. Avitar
Critical Review: MSA Safety vs. Avitar
CLPS  Cut to Hold at ValuEngine
CLPS Cut to Hold at ValuEngine


© 2006-2019 Ticker Report